These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32936321)

  • 1. Differential effects of glutamate N-methyl-D-aspartate receptor antagonists on risky choice as assessed in the risky decision task.
    Yates JR; Horchar MJ; Ellis AL; Kappesser JL; Mbambu P; Sutphin TG; Dehner DS; Igwe HO; Wright MR
    Psychopharmacology (Berl); 2021 Jan; 238(1):133-148. PubMed ID: 32936321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the NMDA receptor antagonists dizocilpine and Ro 63-1908 on delay-discounting and risky decision-making in a gambling task.
    Higgins GA; Silenieks LB; MacMillan C; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2018 Aug; 348():201-210. PubMed ID: 29689373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GluN2B-selective antagonists on delay and probability discounting in male rats: Modulation by delay/probability presentation order.
    Yates JR; Prior NA; Chitwood MR; Day HA; Heidel JR; Hopkins SE; Muncie BT; Paradella-Bradley TA; Sestito AP; Vecchiola AN; Wells EE
    Exp Clin Psychopharmacol; 2018 Dec; 26(6):525-540. PubMed ID: 30035577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.
    Yates JR; Breitenstein KA; Gunkel BT; Hughes MN; Johnson AB; Rogers KK; Shape SM
    Pharmacol Biochem Behav; 2016; 150-151():31-38. PubMed ID: 27642050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I metabotropic glutamate receptor antagonists impair discriminability of reinforcer magnitude, but not risky choice, in a probability-discounting task.
    Yates JR; Chitwood MR; Evans KE; Kappesser JL; Murray CP; Paradella-Bradley TA; Torline BT
    Behav Brain Res; 2019 Jun; 365():77-81. PubMed ID: 30831139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment.
    Higgins GA; Silenieks LB; MacMillan C; Sevo J; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2016 Sep; 311():1-14. PubMed ID: 27180168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of medial prefrontal cortex to decision making involving risk of punishment.
    Orsini CA; Heshmati SC; Garman TS; Wall SC; Bizon JL; Setlow B
    Neuropharmacology; 2018 Sep; 139():205-216. PubMed ID: 30009836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affective and cognitive mechanisms of risky decision making.
    Shimp KG; Mitchell MR; Beas BS; Bizon JL; Setlow B
    Neurobiol Learn Mem; 2015 Jan; 117():60-70. PubMed ID: 24642448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making.
    Floresco SB; Tse MT; Ghods-Sharifi S
    Neuropsychopharmacology; 2008 Jul; 33(8):1966-79. PubMed ID: 17805307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.
    Larkin JD; Jenni NL; Floresco SB
    Psychopharmacology (Berl); 2016 Jan; 233(1):121-36. PubMed ID: 26432096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.
    Yates JR; Gunkel BT; Rogers KK; Hughes MN; Prior NA
    Psychopharmacology (Berl); 2017 Feb; 234(3):461-473. PubMed ID: 27837332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GluN2B N-methyl-D-aspartate receptor and excitatory amino acid transporter 3 are upregulated in primary sensory neurons after 7 days of morphine administration in rats: implication for opiate-induced hyperalgesia.
    Gong K; Bhargava A; Jasmin L
    Pain; 2016 Jan; 157(1):147-158. PubMed ID: 26335908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
    Higgins GA; Ballard TM; Enderlin M; Haman M; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):85-98. PubMed ID: 15759152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable roles for the basolateral amygdala and orbitofrontal cortex in decision-making under risk of punishment.
    Orsini CA; Trotta RT; Bizon JL; Setlow B
    J Neurosci; 2015 Jan; 35(4):1368-79. PubMed ID: 25632115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-acquisition hippocampal blockade of the NMDA receptor subunit GluN2A but not GluN2B sustains spatial reference memory retention.
    Shinohara K; Hata T
    Neurobiol Learn Mem; 2018 Jan; 147():1-8. PubMed ID: 29127002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition.
    Higgins GA; Ballard TM; Huwyler J; Kemp JA; Gill R
    Neuropharmacology; 2003 Mar; 44(3):324-41. PubMed ID: 12604092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in a rat model of risky decision making.
    Orsini CA; Willis ML; Gilbert RJ; Bizon JL; Setlow B
    Behav Neurosci; 2016 Feb; 130(1):50-61. PubMed ID: 26653713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.